Page 134 - Read Online
P. 134

De Robertis et al. Art Int Surg 2023;3:166-79  https://dx.doi.org/10.20517/ais.2023.18                                                  Page 174

               predictors of their histological classification: a study by Permuth et al. suggested that the combination of
               radiomics features with the miRNA genomic classifier (MGC) had an AUC = 0.92 and sensitivity (83%),
                                                                                    [64]
               specificity (89%), PPV (88%), and NPV (85%) for prediction of IPMN malignancy .

               Differential diagnosis
               Radiomics is a promising tool to improve the characterization of focal pancreatic lesions. Zhang et al.
               developed CT and radiomics nomograms for the differentiation between mass-forming pancreatitis (MFP)
               and PDAC in patients with chronic pancreatitis (CP) . 138 patients with histopathologically diagnosed
                                                              [65]
               MFCP or PDAC were retrospectively analyzed. Both models had good performance in differentiating
               between the two entities in the training (AUC = 0.87/0.91) and validation (AUC = 0.94) cohorts. A
               radiomics-based computer-aided diagnosis scheme proposed by Wei et al. had AUC = 0.767, sensitivity =
               0.686, and specificity = 0.709 for preoperative diagnosis of cystic neoplasms .
                                                                              [66]

               Prediction of prognosis
               Tumor grade is a major prognostic factor for pancreatic neoplasms. Chang et al.  and Tikhonova et al.
                                                                                    [67]
                                                                                                        [68]
               reported significant differences in radiomics signatures between PDAC of different grades, with AUC
               ranging from 0.66 to 0.77. Tumor grade is even more important from a prognostic point of view for pNENs.
               Gu et al. included 138 patients with pathologically confirmed pNENs (training cohort, 104 patients;
               validation cohort, 34 patients) . A nomogram integrating tumor margin status and a radiomic signature
                                         [69]
               derived from CT images showed strong discrimination with AUCs of 0.974 and 0.902 in the training and
               validation cohort, respectively.


               Several studies conducted a radiomic analysis to predict features with a negative prognostic role of pNENs.
               In particular, a study  retrospectively analyzed the MR histogram features of 42 patients with pNEN:
                                  [70]
               ADCentropy was higher in G2-3 tumors with AUC = 0.757, sensitivity and specificity of 83.3% and 61.1%,
               while kurtosis was higher in pNENs with vascular infiltration, lymph node and liver metastases (P = 0.008,
               0.021 and 0.008; AUC = 0.820, 0.709 and 0.820). Mori et al. evaluated radiomics features extracted from
               unenhanced CT images and reported AUCs of 0.81/0.81 for the radiomic and clinic-radiological model for
                                                                [71]
               metastases and 0.67/0.72 and 0.68/0.70 for tumor grade . Transcriptional classifiers are key prognostic
               factors of PDAC. Salinas-Miranda et al.  developed a radiomics score that was significantly associated
                                                  [72]
               (coefficient = 0.31) with the four PDAC subtypes (squamous, pancreatic progenitor, immunogenic, and
               aberrantly differentiated endocrine exocrine) classified by Bailey et al.  through gene expression analysis.
                                                                           [73]
               Preoperative staging of pancreatic neoplasms includes the evaluation of vascular involvement, node and
               distant metastases. Rigiroli et al. developed a 5-feature model with AUC = 0.71 for preoperative assessment
               of superior mesenteric artery involvement by PDAC . Bian et al. developed a radiomic score that was
                                                             [74]
                                                                                             [76]
               linked to the possibility of nodal metastasis . Finally, a study that comprised 220 patients  developed a
                                                     [75]
               logistic regression model composed of eight variables that had sensitivity, specificity, PPV, NPV and AUC
               of 58.6%, 91.3%, 75.9%, 82.5%, and 0.850 for prediction of simultaneous liver metastases in PDAC patients.
               Early recurrence after surgery is not uncommon in PDAC patients. Although the reasons for this have not
               been defined with certainty, the availability of a non-invasive biomarker would be clinically useful in
               patients with resectable PDAC to avoid unbeneficial surgery. Tang et al. analyzed 303 PDAC patients; the
               AUC values for prediction of early recurrence of radiomics signatures were 0.80, 0.81, and 0.78 in the
               training, inner validation, and outer validation cohorts, respectively; the AUC values for early recurrence
               were 0.87, 0.88, and 0.85 in the training, internal validation, and external validation cohorts . A study
                                                                                                [77]
               aimed to correlate conventional and radiomics MR features with the risk and the time to metastases after
               surgical resection in patients with resected PDAC ; 120 patients were included. ADC skewness had a
                                                           [78]
               significant impact on the risk of metastases, with HR = 5.22 (P < 0.001): the time to metastases was
               significantly shorter (11.7 vs. 30.8 months, P < 0.001) in patients with an ADC skewness value greater than
   129   130   131   132   133   134   135   136   137   138   139